NYSE · Industrials

Avantor, Inc. AVTR

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.

Biotechnology: Laboratory Analytical Instruments

Company profile

Business mix

  • The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns.
  • It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps.
  • In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services.
  • Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, compound management, cleanroom control, monitoring, maintenance, and sanitization services.

Current key questions

  • Can the company's products, services, or pipeline expand adoption within medical instruments & supplies?
  • How do reimbursement, regulation, clinical data, patents, and commercial execution affect growth?
  • Can margins and cash flow improve while funding research, manufacturing, or go-to-market investment?
Holders 2 Current sample portfolio
Public mentions 0 Videos / interviews / letters
Valuation snapshot
PE N/A FCF 7.02% Buyback 0.43%
2026-06-07

Current firm holders

Firm Weight Value Filing period
Yacktman Asset Management Stephen Yacktman 0.5% $37.2M 2026-03-31
Southeastern Asset Management Mason Hawkins 1.4% $27.6M 2026-03-31

Recent trading changes over the last 1 quarters

Net buyers 1 Last 1 13F filing periods
Net reducers 1 Last 1 13F filing periods
Unchanged holders 0 Share count unchanged
Increase amount $37.2M Estimated from net added shares
Reduction amount $221,919 Estimated from net reduced shares
Net share change / base shares +132.9% +4,716,694 / 3,548,518
Southeastern Asset Management Mason Hawkins 1 filing periods
13F 2026-03-31 Filed 2026-05-15
Minor reduction Shares -0.8% 13F value change -$13.1M
Settlement As of 13F 2026-03-31 · Filed 2026-05-15
Base shares 3,548,518 Last 1 periods -28,306 (-0.8%) Total shares 3,520,212 Value $27.6M
Yacktman Asset Management Stephen Yacktman 1 filing periods
13F 2026-03-31 Filed 2026-05-01
New Shares - 13F value change +$37.2M
Settlement As of 13F 2026-03-31 · Filed 2026-05-01
Base shares 0 Last 1 periods +4,745,000 (New) Total shares 4,745,000 Value $37.2M

Recent mentions

No public mentions.